Apex Biotechnology Corp Financial Flexibility Index
Apex Biotechnology Corp financial flexibility index. Apex Biotechnology Corp (1733) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of NT$8.16 Million (operating CF NT$5.19 Million minus capex NT$2.97 Million) represents 0% of total liabilities (NT$494.69 Million). See free cash flow generation of Apex Biotechnology Corp to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Apex Biotechnology Corp (2002–2024)
Financial flexibility index of Apex Biotechnology Corp from 2002 to 2024. Historical Financial Flexibility Index trend for Apex Biotechnology Corp across 23 annual periods. Check 1733 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Apex Biotechnology Corp Financial Flexibility Index by Year (2002–2024)
Apex Biotechnology Corp financial flexibility index by year from 2002 to 2024. Year-by-year free cash flow to debt coverage for Apex Biotechnology Corp. For the full cash flow conversion analysis, see Apex Biotechnology Corp (1733) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.60x | NT$358.30 Million | NT$328.67 Million | NT$595.70 Million | ▲ +17.8% |
| 2023 | 0.51x | NT$255.37 Million | NT$230.39 Million | NT$500.07 Million | ▲ +432.6% |
| 2022 | 0.10x | NT$66.82 Million | NT$26.62 Million | NT$696.81 Million | ▼ -57.3% |
| 2021 | 0.22x | NT$206.07 Million | NT$179.87 Million | NT$916.91 Million | ▼ -31.3% |
| 2020 | 0.33x | NT$328.93 Million | NT$280.60 Million | NT$1.01 Billion | ▼ -28.3% |
| 2019 | 0.46x | NT$519.11 Million | NT$462.52 Million | NT$1.14 Billion | ▲ +188.1% |
| 2018 | 0.16x | NT$142.85 Million | NT$67.57 Million | NT$901.70 Million | ▲ +68.0% |
| 2017 | 0.09x | NT$97.59 Million | NT$70.83 Million | NT$1.03 Billion | ▼ -78.5% |
| 2016 | 0.44x | NT$336.51 Million | NT$298.06 Million | NT$768.49 Million | ▼ -32.9% |
| 2015 | 0.65x | NT$498.81 Million | NT$472.15 Million | NT$764.69 Million | ▲ +52.5% |
| 2014 | 0.43x | NT$333.02 Million | NT$267.60 Million | NT$778.52 Million | ▼ -53.1% |
| 2013 | 0.91x | NT$732.45 Million | NT$484.77 Million | NT$803.47 Million | ▼ -27.5% |
| 2012 | 1.26x | NT$924.37 Million | NT$509.67 Million | NT$735.18 Million | ▲ +40.4% |
| 2011 | 0.90x | NT$348.08 Million | NT$273.45 Million | NT$388.76 Million | ▼ -54.2% |
| 2010 | 1.95x | NT$626.64 Million | NT$465.59 Million | NT$320.60 Million | ▲ +27.6% |
| 2009 | 1.53x | NT$464.62 Million | NT$391.29 Million | NT$303.31 Million | ▼ -21.1% |
| 2008 | 1.94x | NT$429.70 Million | NT$299.96 Million | NT$221.21 Million | ▼ -5.1% |
| 2007 | 2.05x | NT$419.34 Million | NT$364.62 Million | NT$204.80 Million | ▼ -1.2% |
| 2006 | 2.07x | NT$405.70 Million | NT$363.71 Million | NT$195.73 Million | ▲ +57.8% |
| 2005 | 1.31x | NT$293.44 Million | NT$212.14 Million | NT$223.36 Million | ▼ -64.0% |
| 2004 | 3.65x | NT$469.70 Million | NT$218.54 Million | NT$128.64 Million | ▲ +24.3% |
| 2003 | 2.94x | NT$358.46 Million | NT$302.25 Million | NT$122.00 Million | ▲ +86.4% |
| 2002 | 1.58x | NT$140.62 Million | NT$79.49 Million | NT$89.21 Million | — |